Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by islandphileon Oct 19, 2020 12:22pm
213 Views
Post# 31739312

RE:RE:RE:RE:Incorrect dosing Phase-II Question

RE:RE:RE:RE:Incorrect dosing Phase-II QuestionIt's a totally legit question. Interesting you can't see that.

The last major price change in this stock has delivered the verdict on what the market thinks about that stinker.

And shouldn't the company know who did it? These are highly educated people administring the test, trained to follow protocol and follow the test design, specifically for dosing for God's sake.

So I struggle to understand how this could have happened? And convenient for the timing to hurt the company right when the big payoff was about to take place. And screw up after screw up, management looking after themselves first instead of shareholders... this was our glimmer of hope and it gets sewered like that? And nobody cares? Unbelieveable.
Bullboard Posts